Literature DB >> 16533543

Pharmacological research in pediatrics: From neonates to adolescents.

Natella Y Rakhmanina1, John N van den Anker.   

Abstract

The data guiding the dosing, efficacy and safety of medicines for children have lagged substantially as compared to the information available for adults. As a consequence, pediatricians faced with the prospect of confining their practice to medicines with adequate information have frequently resorted to prescribing medicines for unapproved uses (different dose, frequency, age group, route, indication or formulation). Although a long time in coming, the past decade, have witnessed a new era in drug development for children--an era that is still in its infancy, but which is currently showing signs of maturation. This review will give some of the history and current progress in pharmacological research and pediatric drug development.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16533543     DOI: 10.1016/j.addr.2005.12.001

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  21 in total

1.  Methodological and Ethical Issues in Pediatric Medication Safety Research.

Authors:  Delesha Carpenter; Daniel Gonzalez; George Retsch-Bogart; Betsy Sleath; Benjamin Wilfond
Journal:  Pediatrics       Date:  2017-08-04       Impact factor: 7.124

Review 2.  Pharmacokinetics in neonatal prescribing: evidence base, paradigms and the future.

Authors:  Kate O'Hara; Ian M R Wright; Jennifer J Schneider; Alison L Jones; Jennifer H Martin
Journal:  Br J Clin Pharmacol       Date:  2015-10-26       Impact factor: 4.335

Review 3.  Incidence and nature of medication errors in neonatal intensive care with strategies to improve safety: a review of the current literature.

Authors:  Indra Chedoe; Harry A Molendijk; Suzanne T A M Dittrich; Frank G A Jansman; Johannes W Harting; Jacobus R B J Brouwers; Katja Taxis
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

4.  Pharmacokinetics of penicillin G in infants with a gestational age of less than 32 weeks.

Authors:  Anouk E Muller; Joost DeJongh; Ymka Bult; Wil H F Goessens; Johan W Mouton; Meindert Danhof; John N van den Anker
Journal:  Antimicrob Agents Chemother       Date:  2007-07-23       Impact factor: 5.191

5.  Clinical pharmacological studies in children: From exploratory towards confirmation driven methodology.

Authors:  Karel Allegaert
Journal:  World J Clin Pediatr       Date:  2012-08-08

6.  Neonatal pharmacology: extensive interindividual variability despite limited size.

Authors:  Cuneyt Tayman; Maisa Rayyan; Karel Allegaert
Journal:  J Pediatr Pharmacol Ther       Date:  2011-07

7.  Population pharmacokinetics of gentamicin and dosing optimization for infants.

Authors:  Susanna E Medellín-Garibay; Aída Rueda-Naharro; Silvia Peña-Cabia; Benito García; Silvia Romano-Moreno; Emilia Barcia
Journal:  Antimicrob Agents Chemother       Date:  2014-11-10       Impact factor: 5.191

Review 8.  Fewer infants than older patients in paediatric randomised controlled trials.

Authors:  François Angoulvant; Florentia Kaguelidou; Stephane Dauger; Corinne Alberti
Journal:  Eur J Epidemiol       Date:  2010-06-20       Impact factor: 8.082

Review 9.  Pharmacotherapy of pediatric HIV infection.

Authors:  Natella Rakhmanina; B Ryan Phelps
Journal:  Pediatr Clin North Am       Date:  2012-08-22       Impact factor: 3.278

Review 10.  Considerations in the pharmacologic treatment and prevention of neonatal sepsis.

Authors:  Chris Stockmann; Michael G Spigarelli; Sarah C Campbell; Jonathan E Constance; Joshua D Courter; Emily A Thorell; Jared Olson; Catherine M T Sherwin
Journal:  Paediatr Drugs       Date:  2014-02       Impact factor: 3.022

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.